Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts.
J Exp Med. 2022 Feb 7;219(2):e20210815. doi: 10.1084/jem.20210815. Epub 2022 Jan 14.
J Exp Med. 2022.
PMID: 35029648